MTOR and Parkinson disease: In addition, changes in metabolic signaling resulting from targeting mitochondrial pyruvate carrier are a key proprietor of cellular metabolism, which can regulate mTOR (mammalian target of rapamycin) activation, resulting in a neuroprotective and anti-inflammatory function in several PD models (Ghosh et al., 2016).